Literature DB >> 31268714

Synthesis and Stereochemical Revision of the Aromatic Polyketide NFAT-133.

Hikaru Sato1, Eunsang Kwon2, Yuka Taguchi1, Shinichiro Yoshida2, Shigefumi Kuwahara1, Yusuke Ogura1.   

Abstract

NFAT-133, isolated from Streptomyces sp., is an immunosuppressive, antidiabetic, and antitrypanosomal aromatic polyketide with three contiguous stereocenters. The first enantioselective total synthesis of the proposed structure of NFAT-133 [(10R,11R,12S)-1] and its C10 epimer [(10S,11R,12S)-1] was achieved from a known aromatic ester (5) by a 10-step sequence that featured chiral auxiliary-directed asymmetric alkylation and the Evans asymmetric aldol reaction as the chirality-inducing steps. The 1H and 13C NMR data as well as the specific rotation value of natural NFAT-133 were not identical to those of the proposed structure, but were in good agreement with those of its C10 epimer. This led us to conclude that the absolute configuration of NFAT-133 should be revised to 10S, 11R, and 12S.

Entities:  

Year:  2019        PMID: 31268714     DOI: 10.1021/acs.jnatprod.8b01063

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  Identification and Biological Activity of NFAT-133 Congeners from Streptomyces pactum.

Authors:  Wei Zhou; Priyapan Posri; Xiao-Jing Liu; Zhiran Ju; Wen-Jian Lan; Taifo Mahmud
Journal:  J Nat Prod       Date:  2021-09-14       Impact factor: 4.803

2.  Divergent Asymmetric Synthesis of Panowamycins, TM-135, and Veramycin F Using C-H Insertion with Donor/Donor Carbenes.

Authors:  Benjamin D Bergstrom; Amy T Merrill; James C Fettinger; Dean J Tantillo; Jared T Shaw
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-25       Impact factor: 16.823

3.  Biosynthesis of the Nuclear Factor of Activated T Cells Inhibitor NFAT-133 in Streptomyces pactum.

Authors:  Wei Zhou; Priyapan Posri; Mostafa E Abugrain; Alexandra J Weisberg; Jeff H Chang; Taifo Mahmud
Journal:  ACS Chem Biol       Date:  2020-12-07       Impact factor: 5.100

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.